SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) OverviewSAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) EBIT
EBIT (Earnings Before Interest and Taxes) analysis for BCYPU.
Quarterly EBIT
-$20.00M
↓ 85.64% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$121.67M
↓ 268.91% YoY
Trailing 12 months ending Mar 31, 2026